Investors |


15 May 2018

LexaGene announces that its prototype for more effective pathogen detection is now generating data, and is capable of identifying E. coli and Staph.

Read More

04 April 2018

LexaGene has entered into a collaboration with Ethos Veterinary Health to begin testing canine dog urine samples on LexaGene’s LX6 prototype.

Read More

22 February 2018

LexaGene honored as a Top 50-Ranked TSX Venture company, ranked by share price, trading volume and market capitalization.

Read More